The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency.

Svein Oskar FrigstadAnne HaaberAntal BajorJan FallingborgPer HammarlundOle K BonderupHåkan BlomTerje RannemPer M Hellström

Published in: Gastroenterology research and practice (2017)

Iron isomaltoside is effective with a good safety profile, and high doses reduce the need for retreatment over time. Several patients were anaemic after treatment, indicating that doses were inadequate for full iron correction. This trial is registered with NCT01900197.

Keyphrases

iron deficiency
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
prognostic factors
peritoneal dialysis
randomized controlled trial
patient reported outcomes
replacement therapy